Home
/

Chronic Infection (Hep B/C/HIV/TB)

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Key takeaway:

Blood testing for chronic infections (hepatitis B/C, HIV, TB) uses CRP, ESR, and WBC to reveal systemic inflammatory activity alongside pathogen-specific testing. CRP is best near the low end, ESR in the low-to-mid range, and WBC typically 4–10.5 (mid-range most reassuring); low WBC may help support detection of immune depletion common with HIV progression. Pairing these markers with viral load, CD4 counts, and liver function is associated with linking physiology to long-term outcomes including cirrhosis and cardiovascular risk.

Read more →
Table of contents

Hep B, Hep C, HIV, and TB: The Inflammation Layer of Chronic Infections

Biomarkers for chronic infections like hepatitis B and C, HIV, and tuberculosis act as the body’s “status lights,” showing if the germ is present, how active it is, and how your immune system and organs are responding. Some markers come directly from the pathogen—pieces of the virus or bacterium (antigens), or its genetic material (DNA/RNA)—which confirm ongoing infection and help gauge contagiousness. Others reflect your body’s defense—protective proteins (antibodies) and cellular immune signals (T‑cell responses)—which reveal prior exposure, immune control, or loss of control. A third group shows collateral damage, especially to the liver in hepatitis—tissue injury and inflammation markers that indicate strain on vital organs. Together, these signals map disease stage (acute, chronic, latent), activity (replicating vs. quiet), and impact, guiding who needs treatment, when to start, and whether therapy is working (treatment monitoring). In short, chronic infection biomarkers translate hidden, long-running infections into actionable information for prevention, care, and long‑term health stewardship.

Why Inflammation Markers Add Context to Specific Viral and Bacterial Tests

Chronic infection biomarkers for hepatitis B and C, HIV, and tuberculosis track three things at once: whether the pathogen is present (antigen/antibody and nucleic acid tests), how your immune system is responding (CD4 count for HIV; interferon-gamma for TB), and whether organs are being stressed by inflammation or tissue injury (liver enzymes, CRP, ESR, and white blood cells). They matter because these infections can be silent for years while reshaping immune balance, scarring the liver or lungs, and nudging cardiovascular and metabolic risks.In steady health, CRP sits near the low end, ESR is low to mid-range, and WBCs cluster in the mid-range; reference ranges vary by lab. Typical values suggest quiet immune signaling, though chronic hepatitis or HIV can still be present without big bumps in CRP or ESR. Higher CRP/ESR or WBCs point to active inflammation, flares, or co-infections; TB often raises ESR, hepatitis flares can nudge CRP, and advanced HIV may show high inflammatory markers with falling CD4 cells.When values run low, they tell different stories. Very low CRP and ESR simply reflect minimal systemic inflammation and do not rule out chronic viral infection that is compartmentalized in the liver or latent in tissues. Low WBCs (especially neutrophils or lymphocytes) signal bone marrow suppression, immune depletion, or medication effects; with HIV this can accompany fatigue, frequent infections, mouth ulcers, or fevers. Children tend to have higher baseline WBCs; older adults may show muted CRP/ESR responses. Pregnancy naturally elevates WBC and ESR, so “low” is uncommon in that setting.Big picture, these tests knit together infection status, immune tone, and organ integrity. Tracking them alongside viral load, CD4 counts, and liver function links day-to-day physiology to long-term outcomes like cirrhosis, lung damage, opportunistic infections, and cardiovascular risk.

What Inflammation Bloodwork Adds to a Hep, HIV, or TB Workup

Chronic infections like hepatitis B, hepatitis C, HIV, and tuberculosis can quietly disrupt many body systems over time. These infections may affect energy levels, metabolism, cardiovascular health, cognition, reproductive function, and especially the immune system. At Superpower, we assess your body’s response to these infections by measuring three key biomarkers: C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell count (WBC).CRP is a protein produced by the liver in response to inflammation. ESR measures how quickly red blood cells settle in a test tube, which also reflects inflammation in the body. WBC counts the number of white blood cells, which are crucial for fighting infections. In the context of chronic infections like Hep B, Hep C, HIV, or TB, these markers help reveal whether your immune system is persistently activated or under stress.Stable, healthy levels of CRP, ESR, and WBC suggest that your immune system is not experiencing ongoing inflammation or infection. When these markers are elevated or abnormal, it may indicate that the body is actively responding to a chronic infection, or that there is ongoing tissue damage or immune activation. Persistent changes in these biomarkers can signal that the infection is affecting your body’s stability and overall function.It’s important to note that CRP, ESR, and WBC can be influenced by factors such as age, pregnancy, recent illness, certain medications, and even laboratory methods. These variables are considered when interpreting your results to ensure an accurate understanding of your health status.

FAQs

This testing looks for long-term infections and how your immune system is responding. It includes pathogen-specific assays for hepatitis B and C, HIV, and tuberculosis using antigen/antibody screens and, when indicated, nucleic acid tests (PCR). Superpower also tests your blood for CRP, ESR, and WBC to quantify acute-phase inflammation, red cell sedimentation, and white cell count. Together, these results indicate active infection, past exposure, immunity, or nonspecific inflammation that needs clinical context.

Chronic infections can be silent yet damage core systems—liver (hepatitis B/C), immune system (HIV), and lungs (TB). Testing clarifies current infection, prior exposure, or immunity, helping reduce complications and transmission and guiding follow-up. System markers—CRP, ESR, and WBC—show how active your immune response is now, helping distinguish stable past infection from active disease or a different inflammatory process.

Yes. With Superpower, our team member can organize a professional blood draw in your home for Hep B/C/HIV/TB along with CRP, ESR, and WBC. Samples are handled to clinical standards and delivered to the lab, with results returned securely.

It depends on risk, exposure, symptoms, and monitoring needs. Many adults benefit from one-time screening, with repeat testing after new exposure, during pregnancy, when starting or monitoring treatment, or if you live or work in higher-risk settings. If a result is positive, confirmatory testing and clinical monitoring determine follow-up intervals. CRP, ESR, and WBC are repeated as needed to track activity, not on a fixed schedule.

Timing and immune status matter. Early after exposure (the window period), antibody tests can be negative despite infection; immunosuppression can blunt responses. Hepatitis B vaccination changes antibody patterns. CRP rises rapidly with inflammation (acute-phase response), ESR increases with shifts in plasma proteins or anemia, and WBC varies with infection, stress, corticosteroids, or marrow conditions. Pregnancy, recent surgery, strenuous exercise, and sample handling can also influence results.

No special fasting is needed. Good hydration makes collection easier. Avoid vigorous exercise immediately beforehand, as it can transiently raise WBC and CRP. Corticosteroids, biologics, and other immunomodulators can lower inflammatory markers; documentation at collection helps interpretation. Testing can be done any time; minor day–night variation is not clinically significant for these markers.

References

  1. McMahon, B. J. (2009). The natural history of chronic hepatitis B virus infection. Hepatology, 49(5 Suppl), S45-S55. https://doi.org/10.1002/hep.22898
  2. Hogg, R. S., Yip, B., Chan, K. J., Wood, E., Craib, K. J., O'Shaughnessy, M. V., & Montaner, J. S. (2001). Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA, 286(20), 2568-2577. https://doi.org/10.1001/jama.286.20.2568
  3. Zhou, G., Luo, Q., Luo, S., Teng, Z., Ji, Z., Yang, J., Wang, F., Wen, S., Ding, Z., Li, L., Chen, T., Abi, M. E., Jian, M., Luo, L., Liu, A., & Bao, F. (2020). Interferon-gamma release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis. The Lancet Infectious Diseases, 20(12), 1457-1469. https://doi.org/10.1016/s1473-3099(20)30276-0
  4. Campbell, J. R., Winters, N., & Menzies, D. (2020). Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis. BMJ, 368, m549. https://doi.org/10.1136/bmj.m549
  5. Gabay, C., & Kushner, I. (1999). Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine, 340(6), 448-454. https://doi.org/10.1056/nejm199902113400607

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey